In an adult with normal hepatic function, can prednisone be used instead of prednisolone for the initial step‑1 steroid trial?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, prednisone can be used instead of prednisolone for step-1 steroid therapy in adults with normal hepatic function.

Prednisone is identical to prednisolone and is routinely used in North America as first-line therapy for autoimmune hepatitis, with the 2025 British Society of Gastroenterology guidelines explicitly stating they are interchangeable in patients with normal liver function 1.

Key Evidence Supporting Interchangeability

The most recent 2025 BSG guidelines clearly state: "Prednisone is identical to prednisolone and is used in North America" 1. This guideline uses the term "predniso(lo)ne" throughout to indicate equivalence, and all dosing recommendations apply equally to both formulations 1.

Pharmacokinetic Basis

In patients with normal hepatic function, prednisone is rapidly and efficiently converted to its active form, prednisolone:

  • Conversion occurs within 0.3 hours of administration 2
  • Bioavailability approximates 100% and is comparable whether prednisone or prednisolone is given 3
  • Research demonstrates rapid interconversion equilibrium between the two corticosteroids 4

Recommended Dosing Regimen

For step-1 induction therapy in adults with normal liver function:

  • Initial dose: 0.5 mg/kg/day (maximum 40 mg/day) of prednisone or prednisolone 1
  • Administration: Single morning dose before 9 am 5
  • Combination therapy: Should be given with azathioprine 1 mg/kg/day as standard first-line treatment 1
  • Tapering: Reduce by 5-10 mg increments every 2 weeks over 3 months, aiming to get below 20 mg as soon as possible 1

Critical Caveat: Hepatic Dysfunction

This equivalence only applies to patients with normal hepatic function. In patients with impaired liver function:

  • Conversion of prednisone to prednisolone becomes impaired 6
  • Patients with severely impaired liver function show only 53% of expected prednisolone levels after prednisone administration 6
  • Prednisolone should be preferred over prednisone in patients with cirrhosis or significant hepatic impairment 6

Practical Considerations

The choice between prednisone and prednisolone in normal hepatic function is primarily based on:

  • Geographic availability: Prednisone is standard in North America; prednisolone is more common in Europe and UK
  • Formulary considerations: Use whichever is readily available at your institution
  • Cost and accessibility: Both are equally effective when liver function is normal

The 2025 guidelines make no distinction in efficacy, safety, or outcomes between the two formulations when used in patients without hepatic impairment 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.